How much does a box of generic adagrasib cost?

Adagrasib, also known as MRTX849, is a targeted inhibitor used to treat tumors. Its mechanism of action is mainly to inhibit the activity of RAS mutated proteins, which are common in a variety of cancers, including lung cancer, colorectal cancer and other solid tumors.

Adagrasib is not yet available in the country, so patients cannot purchase it domestically and need to purchase adagrasib through overseas channels. The foreign original drug of adagrasib is mainly the original American drug, which is very expensive. The price is more than 180,000 yuan, which is simply unaffordable for ordinary families.

Fortunately, foreign generic drugs have been on the market recently, mainly the Laos Lucius Adagrasibu generic drug. A box only costs about 4,000 to 5,000 yuan, and the ingredients of the original drug and the generic drug are basically the same.

The research and development of adagrasib is aimed at overcoming the challenges of RAS mutations in tumor treatment. RASmutations allow tumor cells to proliferate and grow uncontrollably, making them difficult to treat. Therefore, the emergence of adagrasib is regarded as an important medical breakthrough.

Clinical trials have shown that adagrasib exhibits significant anti-tumor activity in certain tumor types. For example, the drug has shown encouraging efficacy in some patients with non-small cell lung cancer, particularly those carrying the KRAS G12C mutation. In addition, adagrasib has also shown potential therapeutic effects in other cancer types, such as colorectal cancer and thyroid cancer.

However, like many other antineoplastic drugs, adagrasib carries some risks of side effects and drug resistance. These side effects may include nausea, fatigue, rash, etc., and resistance may develop with long-term use.

Overall, adagrasib represents an important advance in the field of cancer treatment, especially for patients with tumors with RAS mutations. As this drug is further studied and clinically applied, a clearer understanding will emerge of its potential and limitations in treating cancer.